SCHEMBL18952999

SCHEMBL18952999

C[C@@H]1CC[C@@H](N)[C@H](N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14504629 1.00
SCHEMBL259022 1.00
SCHEMBL18952975 1.00
SCHEMBL3963519 1.00
SCHEMBL20073065 1.00
SCHEMBL18952998 1.00
Sulfuric Acid SCHEMBL3967626 0.85 KDM4E (0.35)
SCHEMBL15461419 0.79
SCHEMBL23519808 0.79
SCHEMBL15102673 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11572379-B2 Monomaleimide-functionalized platinum compounds for cancer therapy MEDIZINISCHE UNIVERSITÄT WIEN (AT) 2023-02-07 US disclosed
CN-108368143-B Monomaleimide functionalized platinum compounds for cancer therapy 维也纳医科大学 2022-02-01 CN disclosed
EP-3386997-B1 MONOMALEIMIDE-FUNCTIONALIZED PLATINUM COMPOUNDS FOR CANCER THERAPY UNIV WIEN MED (AT) 2021-06-30 EP disclosed
US-20210002313-A1 MONOMALEIMIDE-FUNCTIONALIZED PLATINUM COMPOUNDS FOR CANCER THERAPY MEDIZINISCHE UNIVERSITÄT WIEN (AT) 2021-01-07 US disclosed
US-10723748-B2 Monomaleimide-functionalized platinum compounds for cancer therapy MEDIZINISCHE UNIVERSITÄT WIEN (AT) 2020-07-28 US disclosed
US-20180354979-A1 MONOMALEIMIDE-FUNCTIONALIZED PLATINUM COMPOUNDS FOR CANCER THERAPY Universität Wien (AT) 2018-12-13 US disclosed
EP-3386997-A1 MONOMALEIMIDE-FUNCTIONALIZED PLATINUM COMPOUNDS FOR CANCER THERAPY Medizinische Universität Wien (AT) 2018-10-17 EP disclosed
WO-2017097986-A1 MONOMALEIMIDE-FUNCTIONALIZED PLATINUM COMPOUNDS FOR CANCER THERAPY MEDIZINISCHE UNIVERSITÄT WIEN (AT) 2017-06-15 WO disclosed